Ignite Creation Date:
2024-05-06 @ 2:18 PM
Last Modification Date:
2024-10-26 @ 1:28 PM
Study NCT ID:
NCT04275518
Status:
RECRUITING
Last Update Posted:
2023-08-30
First Post:
2020-02-05
Brief Title:
A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS
Sponsor:
Ascentage Pharma Group Inc
Organization:
Ascentage Pharma Group Inc
Organization Data
Organization:
Ascentage Pharma Group Inc
Class:
INDUSTRY
Study ID:
APG115AC101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ascentage Pharma Group Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Suzhou Yasheng Pharmaceutical Co Ltd | INDUSTRY |